351 related articles for article (PubMed ID: 12819188)
1. The mature bone morphogenetic protein-2 is aberrantly expressed in non-small cell lung carcinomas and stimulates tumor growth of A549 cells.
Langenfeld EM; Calvano SE; Abou-Nukta F; Lowry SF; Amenta P; Langenfeld J
Carcinogenesis; 2003 Sep; 24(9):1445-54. PubMed ID: 12819188
[TBL] [Abstract][Full Text] [Related]
2. Expression of bone morphogenetic proteins in human lung carcinomas.
Langenfeld EM; Bojnowski J; Perone J; Langenfeld J
Ann Thorac Surg; 2005 Sep; 80(3):1028-32. PubMed ID: 16122479
[TBL] [Abstract][Full Text] [Related]
3. Influence of BMPs on the formation of osteoblastic lesions in metastatic prostate cancer.
Feeley BT; Gamradt SC; Hsu WK; Liu N; Krenek L; Robbins P; Huard J; Lieberman JR
J Bone Miner Res; 2005 Dec; 20(12):2189-99. PubMed ID: 16294272
[TBL] [Abstract][Full Text] [Related]
4. Bone morphogenetic protein-2 stimulates angiogenesis in developing tumors.
Langenfeld EM; Langenfeld J
Mol Cancer Res; 2004 Mar; 2(3):141-9. PubMed ID: 15037653
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of noggin inhibits BMP-mediated growth of osteolytic prostate cancer lesions.
Feeley BT; Krenek L; Liu N; Hsu WK; Gamradt SC; Schwarz EM; Huard J; Lieberman JR
Bone; 2006 Feb; 38(2):154-66. PubMed ID: 16126463
[TBL] [Abstract][Full Text] [Related]
6. Bone morphogenetic protein 2 stimulation of tumor growth involves the activation of Smad-1/5.
Langenfeld EM; Kong Y; Langenfeld J
Oncogene; 2006 Feb; 25(5):685-92. PubMed ID: 16247476
[TBL] [Abstract][Full Text] [Related]
7. Bone morphogenetic protein 3B silencing in non-small-cell lung cancer.
Dai Z; Popkie AP; Zhu WG; Timmers CD; Raval A; Tannehill-Gregg S; Morrison CD; Auer H; Kratzke RA; Niehans G; Amatschek S; Sommergruber W; Leone GW; Rosol T; Otterson GA; Plass C
Oncogene; 2004 Apr; 23(20):3521-9. PubMed ID: 15116090
[TBL] [Abstract][Full Text] [Related]
8. Integrin alpha 11 regulates IGF2 expression in fibroblasts to enhance tumorigenicity of human non-small-cell lung cancer cells.
Zhu CQ; Popova SN; Brown ER; Barsyte-Lovejoy D; Navab R; Shih W; Li M; Lu M; Jurisica I; Penn LZ; Gullberg D; Tsao MS
Proc Natl Acad Sci U S A; 2007 Jul; 104(28):11754-9. PubMed ID: 17600088
[TBL] [Abstract][Full Text] [Related]
9. Differential expression of CXCR4 is associated with the metastatic potential of human non-small cell lung cancer cells.
Su L; Zhang J; Xu H; Wang Y; Chu Y; Liu R; Xiong S
Clin Cancer Res; 2005 Dec; 11(23):8273-80. PubMed ID: 16322285
[TBL] [Abstract][Full Text] [Related]
10. Bone morphogenetic protein 2 (BMP-2) induces in vitro invasion and in vivo hormone independent growth of breast carcinoma cells.
Clement JH; Raida M; Sänger J; Bicknell R; Liu J; Naumann A; Geyer A; Waldau A; Hortschansky P; Schmidt A; Höffken K; Wölft S; Harris AL
Int J Oncol; 2005 Aug; 27(2):401-7. PubMed ID: 16010421
[TBL] [Abstract][Full Text] [Related]
11. Down-regulation of hepatoma-derived growth factor inhibits anchorage-independent growth and invasion of non-small cell lung cancer cells.
Zhang J; Ren H; Yuan P; Lang W; Zhang L; Mao L
Cancer Res; 2006 Jan; 66(1):18-23. PubMed ID: 16397209
[TBL] [Abstract][Full Text] [Related]
12. Bone morphogenetic proteins secreted by breast cancer cells upregulate bone sialoprotein expression in preosteoblast cells.
Bunyaratavej P; Hullinger TG; Somerman MJ
Exp Cell Res; 2000 Nov; 260(2):324-33. PubMed ID: 11035927
[TBL] [Abstract][Full Text] [Related]
13. [shRNA-mediated insulin-like growth factor I receptor gene silencing inhibits cell proliferation, induces cell apoptosis, and suppresses tumor growth in non-small cell lung cancer: in vitro and in vivo experiments].
Dong AQ; Kong MJ; Ma ZY; Qian JF; Fan JQ; Xu XH
Zhonghua Yi Xue Za Zhi; 2007 Jun; 87(21):1506-9. PubMed ID: 17785094
[TBL] [Abstract][Full Text] [Related]
14. Compactin and simvastatin, but not pravastatin, induce bone morphogenetic protein-2 in human osteosarcoma cells.
Sugiyama M; Kodama T; Konishi K; Abe K; Asami S; Oikawa S
Biochem Biophys Res Commun; 2000 May; 271(3):688-92. PubMed ID: 10814523
[TBL] [Abstract][Full Text] [Related]
15. Lineage-restricted expression of bone morphogenetic protein genes in human hematopoietic cell lines.
Detmer K; Steele TA; Shoop MA; Dannawi H
Blood Cells Mol Dis; 1999; 25(5-6):310-23. PubMed ID: 10660478
[TBL] [Abstract][Full Text] [Related]
16. Human non-small cell lung tumors and cells derived from normal lung express both estrogen receptor alpha and beta and show biological responses to estrogen.
Stabile LP; Davis AL; Gubish CT; Hopkins TM; Luketich JD; Christie N; Finkelstein S; Siegfried JM
Cancer Res; 2002 Apr; 62(7):2141-50. PubMed ID: 11929836
[TBL] [Abstract][Full Text] [Related]
17. Bone morphogenetic protein-6 is a marker of serous acinar cell differentiation in normal and neoplastic human salivary gland.
Heikinheimo KA; Laine MA; Ritvos OV; Voutilainen RJ; Hogan BL; Leivo IV
Cancer Res; 1999 Nov; 59(22):5815-21. PubMed ID: 10582704
[TBL] [Abstract][Full Text] [Related]
18. Differential expression and regulation of bone morphogenetic protein 7 in breast cancer.
Schwalbe M; Sänger J; Eggers R; Naumann A; Schmidt A; Höffken K; Clement JH
Int J Oncol; 2003 Jul; 23(1):89-95. PubMed ID: 12792780
[TBL] [Abstract][Full Text] [Related]
19. The effect of statins in colorectal cancer is mediated through the bone morphogenetic protein pathway.
Kodach LL; Bleuming SA; Peppelenbosch MP; Hommes DW; van den Brink GR; Hardwick JC
Gastroenterology; 2007 Oct; 133(4):1272-81. PubMed ID: 17919499
[TBL] [Abstract][Full Text] [Related]
20. Modulation of bone morphogenetic protein-2 and bone morphogenetic protein-4 gene expression in osteoblastic cell lines.
Virdi AS; Cook LJ; Oreffo RO; Triffitt JT
Cell Mol Biol (Noisy-le-grand); 1998 Dec; 44(8):1237-46. PubMed ID: 9874511
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
